# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barclays analyst Benjamin Budish maintains Blackstone (NYSE:BX) with a Equal-Weight and raises the price target from $125 to...
Piper Sandler analyst Crispin Love maintains Blackstone (NYSE:BX) with a Overweight and lowers the price target from $143 to...
Cramer calls Ferguson a "very, very good" company, but recommended owning Trane Technologies or Carrier Global 'in ...
Blackstone Inc. is reportedly finalizing a deal to sell Alinamin Pharmaceutical to MBK Partners for $2.17 billion. Blackstone a...
Goldman Sachs initiates coverage on Digital Realty Trust with Buy rating and $175 price target. Analyst anticipates surpassing ...
- Bloomberg
Sanofi wants $20 billion for its consumer health division, attracting interest from major firms like Advent and PAI Partners.